LSD is a powerful illegal psychedelic drug with the potential for serious mental and physical harm. That didn’t stop the CIA ...

Psychedelics are poised to revolutionize wellness by offering new approaches to mental health, personal growth, and spiritual ...

The popularity of psilocybin is fast-rising, with an estimated 8 million American adults using it in 2023.  The percentage of US adults who have used psilocybin at least once in their lifetime, ...

As Colorado becomes the second state to legalize psychedelic therapy, a clash is playing out in Colorado Springs, where ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Mental health professionals have made great advancements in the therapeutic use of psychedelic drugs in recent years.

This story first appeared in Colorado Newsline. Coloradans will soon be able to take psychedelic mushrooms in a regulated ...

SciSparc has become one of the most talked-about stocks today, but what’s behind this unexpected surge? Let’s dive deep into what’s driving the action and how it compares to the broader market.

SciSparc teams up with Clearmind Medicine on innovative therapies for binge behaviors and secures FDA approval for a Tourette Syndrome Phase 2b trial.

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

Mind-opening psychedelic drugs can provide a needed boost to people dealing with cancer or struggling with alcoholism, ...

Tryptamine Therapeutics ( (AU:TYP) ) has shared an announcement.